CNS Therapeutics
Saint Paul
About CNS Therapeutics
CNS Therapeutics is a private company based in St. Paul, Minn. CNS Therapeutics develops and markets safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system to treat neurological disorders and chronic pain. In addition to its first FDA-approved product, Gablofen, CNS Therapeutics is currently collaborating with U.S. and international scientific experts to develop and test new treatments for pain and Parkinson's disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $10.1M
- Funding stage: M&A
- Last round: Series Unknown (Dec 2012)
- Website: cnstherapeutics.com
- Phone: +1 800.778.7898
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/cns-therapeutics-3397658 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.